Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details 1)

v3.19.2
Stock Based Compensation (Details 1)
$ / shares in Units, $ in Thousands
3 Months Ended
Jun. 30, 2019
USD ($)
$ / shares
shares
Stock Grants Outstanding, Beginning | shares 350,000
Number of Stock Grants Granted | shares 0
Number of Stock Grants Exercised/Vested | shares (50,000)
Forfeited/cancelled/expired | shares 0
Stock Grants Outstanding, Ending | shares 300,000
Stock Grants Exercisable, Ending | shares 60,000
Weighted Average Exercise Price Outstanding, Beginning $ 1.98
Weighted Average Exercise Price Granted 0.00
Weighted Average Exercise Price Exercised 1.98
Weighted Average Exercise Price Forfeited/cancelled/expired 0.00
Weighted Average Exercise Price Outstanding, Ending 1.98
Weighted Average Exercise Price Exercisable, Ending $ 1.98
Weighted Average Remaining Contractual Life, Options Outstanding, Beginning 8 years 6 months 4 days
Weighted Average Remaining Contractual Life, Options Outstanding, Ending 8 years 3 months 5 days
Weighted Average Remaining Contractual Life (in years) Exercisable 8 years 3 months 5 days
Aggregate Intrinsic Value Outstanding, Beginning | $ $ 2,342
Aggregate Intrinsic Value Granted | $ 0
Aggregate Intrinsic Value Exercised | $ $ 394
Aggregate Intrinsic Value Forfeited/cancelled/expired $ 0
Aggregate Intrinsic Value Options Outstanding, Ending | $ $ 2,679
Aggregate Intrinsic Value Exercisable, Ending | $ $ 536
Restricted Stock [Member]  
Stock Grants Outstanding, Beginning | shares 2,275,000
Number of Stock Grants Granted | shares 0
Number of Stock Grants Exercised/Vested | shares 0
Forfeited/cancelled/expired | shares 0
Stock Grants Outstanding, Ending | shares 2,275,000
Weighted Average Fair Value Outstanding, Beginning $ 4,777
Weighted Average Fair Value Granted 0
Weighted Average Fair Value Vested 0
Weighted Average Fair Value Forfeited/cancelled/expired 0
Weighted Average Fair Value Outstanding, Ending $ 4,777